Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Other financing activities: 2015-2018

Historic Other financing activities for Assembly Biosciences (ASMB) over the last 3 years, with Sep 2018 value amounting to -$543,780.

  • Assembly Biosciences' Other financing activities fell 451.84% to -$543,780 in Q3 2018 from the same period last year, while for Sep 2018 it was -$524,726, marking a year-over-year decrease of 138.03%. This contributed to the annual value of -$84,192 for FY2017, which is 44.64% down from last year.
  • Latest data reveals that Assembly Biosciences reported Other financing activities of -$543,780 as of Q3 2018, which was down 2,983.70% from $18,857 recorded in Q2 2018.
  • Assembly Biosciences' 5-year Other financing activities high stood at $86,231 for Q4 2017, and its period low was -$543,780 during Q3 2018.
  • Over the past 3 years, Assembly Biosciences' median Other financing activities value was -$21,646 (recorded in 2016), while the average stood at -$68,487.
  • As far as peak fluctuations go, Assembly Biosciences' Other financing activities skyrocketed by 293.32% in 2017, and later slumped by 724.97% in 2018.
  • Over the past 4 years, Assembly Biosciences' Other financing activities (Quarterly) stood at -$27,032 in 2015, then tumbled by 85.05% to -$50,022 in 2016, then spiked by 272.39% to $86,231 in 2017, then plummeted by 451.84% to -$543,780 in 2018.
  • Its Other financing activities was -$543,780 in Q3 2018, compared to $18,857 in Q2 2018 and -$86,034 in Q1 2018.